Latest filing published 19 Aug 2024 for Astera Labs, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +37.1%Entry US$2.59 · Close at T+365 US$3.55
- +136.7%Entry US$1.09 · Close at T+365 US$2.58
- +33.5%Entry US$1.58 · Close at T+365 US$2.11
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sutter Hill Ventures: trading record in brief
This profile gathers the share dealings of Sutter Hill Ventures across 10 companies, led by Mattersight Corp, Corcept Therapeutics Inc and Cardica Inc. The record holds 127 filings, for trades running from 8 February 2006 to 15 August 2024.
Market trades split into 66 purchases (€18.7M) and 5 sales (€14.8M). The net balance comes to €4.0M on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 8 share grants.
Half of the purchases are above €66k and half below. Ninety days after publication, 3 purchases show a median change of +8.1%, with the price up in 67% of them. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 19 August 2024, reports a transaction in Astera Labs, Inc. The last insider purchase was made public on 3 July 2018, 3,050 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sutter Hill Ventures
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,587,196 shares0Common StockSEC:0001415889-24-021608:0
- 99,053 sharesCommon StockSEC:0001415889-24-009008:1
- 16,761,590 sharesCommon StockSEC:0001415889-24-009008:2
- 1,573,520 sharesCommon StockSEC:0001415889-24-009008:3
- 11,295 sharesCommon StockSEC:0001415889-24-009008:4
- 1,815 sharesCommon StockSEC:0001415889-24-009008:5
- 130,831 sharesCommon StockSEC:0001415889-24-009008:6
- 210,013 sharesCommon StockSEC:0001415889-24-009008:7
- 198,091 sharesCommon StockSEC:0001415889-24-009008:0
- 27,309,222 shares0Class A Common StockSEC:0001225208-21-004874:0
- 27,309,222 shares0Class A Common StockSEC:0001225208-21-004635:0
- 1,052,146 shares0Common StockSEC:0001225208-18-011387:0
- 945,326 shares0Common StockSEC:0001225208-18-011387:1
- 774,165 shares0Common StockSEC:0001225208-18-011387:2
- 134,735 shares@ US$16.00100.0% of flowCommon StockSEC:0001225208-18-011387:3Canonical exit: 30 Sept 2018 (T+90)
- 8,614,633 shares0Common StockSEC:0001225208-17-018257:0
- 888,690 shares0Common StockSEC:0001225208-17-016390:0
- 606,386 shares0Common StockSEC:0001225208-17-016390:1
- 479,145 shares0Common StockSEC:0001225208-17-016390:2
- 105,369 shares@ US$7.00Common StockSEC:0001225208-17-016390:3
- 271,391 shares0Common StockSEC:0001225208-17-010829:0
- 1,567,084 shares0Common StockSEC:0001225208-17-010826:0
- 203,543 shares@ US$3.65100.0% of flowCommon StockSEC:0001225208-17-010829:1Canonical exit: 30 Aug 2017 (T+90)
- 2,975,941 shares0Common StockSEC:0001225208-17-008267:0
- 2,799,328 shares0Common StockSEC:0001225208-17-008267:1
25 of 64 declarations
